Drug Profile
Intransal anthrax vaccine - Altimmune
Alternative Names: AdVAV; NasoShield™Latest Information Update: 22 Apr 2022
Price :
$50
*
At a glance
- Originator Vaxin
- Developer Altimmune
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anthrax